CSPG4


Summary: A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in CSPG4


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IPI GO:0019901 protein kinase binding
BP IEA GO:0000187 activation of MAPK activity
BP IEA GO:0001525 angiogenesis
BP IEA GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway
BP IEA GO:0008283 cell proliferation
BP IEA GO:0008347 glial cell migration
Showing 1 to 6 of 23 rows rows per page

Gene expression in normal tissue: CSPG4

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in CSPG4


Loading, please wait...
Database
Pathway ID
Pathway Des.
pid integrin1_pathway Beta1 integrin cell surface interactions
wikipathways WP2431 Spinal Cord Injury
reactome R-HSA-1430728 Metabolism
reactome R-HSA-1630316 Glycosaminoglycan metabolism
reactome R-HSA-1638091 Heparan sulfate/heparin (HS-GAG) metabolism
reactome R-HSA-1643685 Disease
Showing 1 to 6 of 20 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD103 SN-38 3
iGMDRD121 GMX1778 2
iGMDRD481 Dactolisib 3
iGMDRD77 Itraconazole 2
Showing 1 to 4 of 32 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in CSPG4

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​